StoneX Group Inc. - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 31 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
StoneX Group Inc. ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$27,000
-25.0%
13,4420.0%0.00%
-33.3%
Q1 2021$36,00013,4420.01%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders